profit from every $100 of sales.

Basel Medical Group Ltd Ordinary Shares
Trading close to its lowest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
It has no yearly profit to compare the price with.
of earnings would pay off all its debt.
Money in, money out
What Basel Medical Group Ltd Ordinary Shares sold, what it kept, and what it did with the cash.
Sales went from SGD 10.7 million in 2022 to SGD 11.3 million in 2025, with -SGD 10.6 million of profit last year.
Basel Medical Group Ltd Ordinary Shares vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
Basel Medical Group Ltd Ordinary Shares | No profit yet | ||
Centene | No profit yet | ||
Clover Health Investments | No profit yet | ||
Alignment Healthcare | No profit yet | ||
Caring Brands | No profit yet |
AI analysis
An AI analyst reads Basel Medical Group Ltd Ordinary Shares's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of SGD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 11 | 10 | 10 | 11 | |
| 8 | 7 | 8 | 9 | |
| 2 | 2 | 2 | -2 | |
| 3 | 3 | 3 | -10 | |
| 2 | 2 | 2 | -11 | |
| 0.12 | 0.10 | 0.11 | – | |
| 79.6% | 75.9% | 77.6% | 77.5% | |
| 23.2% | 21.4% | 21.8% | -19.2% | |
| 18.6% | 18.4% | 20.6% | -94.0% |
Balance sheet
| In millions of SGD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 17 | 15 | 16 | 19 |
| Cash | 2 | 1 | 2 | 3 |
| Total debt | 10 | 7 | 4 | 5 |
| Total liabilities | 13 | 10 | 9 | 13 |
| 4 | 5 | 8 | 5 | |
| 16 | 18 | 18 | – | |
| 15.4% | 14.7% | 17.2% | -81.5% | |
| 53.4% | 32.5% | 27.4% | -195.7% |
Cash flow
| In millions of SGD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 3 | 3 | 3 | -3 | |
| 0 | 0 | 0 | 0 | |
| 3 | 3 | 3 | -4 | |
| Dividends paid | – | – | – | – |
| – | – | – | – | |
| – | – | – | – |
Valuation
- –
- –
- –
- 0.0×
- 0.9×
- –
- –
- -36.4%
- -106.9%
- 0.0%
Profitability
- 77.5%
- -19.2%
- -94.0%
- -98.2%
- -25.5%
- -25.0%
- -194.6%
- -71.7%
- -35.4%
- –
Growth
- +2.0%
- –
- −275.9%
- –
- –
Financial health
- –
- 0.70
- 20.3%
- -10.7×
- 1.23
- 1.19
- 0.67
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/7Passes 0 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Questions about Basel Medical Group Ltd Ordinary Shares
Is Basel Medical Group Ltd Ordinary Shares a good stock to buy?
A business with weak numbers that is not profitable yet. 0 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Basel Medical Group Ltd Ordinary Shares AI analysis
What does Basel Medical Group Ltd Ordinary Shares do?
Basel Medical Group Ltd provides healthcare services. The company offers services in the areas of medical specialists, medical supplies and equipment, medical technology, and pharmaceuticals. The company was incorporated in 2023 and is based in Singapore. It is in Medical - Healthcare Plans.
Does Basel Medical Group Ltd Ordinary Shares pay a dividend?
No. Basel Medical Group Ltd Ordinary Shares does not pay a dividend at the moment.
Is Basel Medical Group Ltd Ordinary Shares stock halal?
No. Basel Medical Group Ltd Ordinary Shares does not pass our halal screen: its debt is 51% of its market value, at or above the 33% limit. How we check
How has Basel Medical Group Ltd Ordinary Shares stock done over the past year?
Down 59.3% over the past twelve months, to $0.57. It traded between $0.57 and $10.74 and is 94.7% below its high.
Who are Basel Medical Group Ltd Ordinary Shares's competitors?
The largest listed companies in the same industry are Centene, Clover Health Investments, Alignment Healthcare and Caring Brands. The peers table on this page compares their profit, growth and price with Basel Medical Group Ltd Ordinary Shares's.
Prices: daily closes to Nov 12, 2026. Fundamentals: company reports via invest-like data.



